Literature DB >> 22366438

The role of IL-8 in the SDF-1α/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma.

Kai-Chun Li1, Ying-Hsuan Huang, Ching-Yin Ho, Chia-Yu Chu, Shih-Ting Cha, Hung-Huey Tsai, Jenq-Yuh Ko, Cheng-Chi Chang, Ching-Ting Tan.   

Abstract

Stromal cell-derived factor-1 (SDF-1) (CXCL12) has been observed to promote laryngeal and hypopharyngeal squamous cell carcinomas (LHSCCs) invasion through cooperation with its receptor CXCR4. Here, we further explore the angiogenesis mechanism induced by SDF-1/CXCR4 interaction in LHSCCs. Immunohistochemistry (IHC) reveals the significant correlation between CXCR4 and angiogenesis in tumors. After blocking the function of CXCR4 by specific inhibitor AMD3100 and neutralized antibody 12G5 or inhibiting the expression by siRNA, we were able to disrupt the HUVECs tube formation, demonstrating that SDF-1/CXCR4 indeed regulated the angiogenesis mechanism. The angiogenesis profiling from angiogenesis array and reverse transcription polymerase chain reaction indicates that IL-8 can be significantly triggered by SDF-1/CXCR4 interaction in LHSCCs. We also demonstrate that IL-8 secretion mechanism is regulated by Akt phosphorylation after SDF-1 stimulation. These results point out the importance of SDF-1/CXCR4 interaction in LHSCCs angiogenesis. The angiogenic factor IL-8 would be triggered by the cooperation of SDF-1 and CXCR4 through an Akt-dependent pathway. This provides a new targeting therapy utility, disrupting SDF-1/CXCR4 interaction combined with downstream-induced angiogenic factors in LHSCCs would be beneficial to improve clinical outcome.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366438     DOI: 10.1016/j.oraloncology.2012.01.006

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  11 in total

1.  CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.

Authors:  Na Chen; Xiao Jiang; Juan Wang; Tong Wu; Bin Cheng; Juan Xia
Journal:  Tumour Biol       Date:  2015-08-02

2.  Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.

Authors:  Margret Rave-Fränk; Narges Tehrany; Julia Kitz; Martin Leu; Hanne Elisabeth Weber; Peter Burfeind; Henning Schliephake; Martin Canis; Tim Beissbarth; Holger Michael Reichardt; Hendrik Andreas Wolff
Journal:  Strahlenther Onkol       Date:  2015-09-15       Impact factor: 3.621

3.  Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis.

Authors:  Zhiwei Zhao; Shichao Wang; Yingbo Lin; Yali Miao; Ye Zeng; Yongmei Nie; Peng Guo; Guangyao Jiang; Jiang Wu
Journal:  Oncol Lett       Date:  2017-04-13       Impact factor: 2.967

4.  MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells.

Authors:  Hua-Nan Luo; Zheng-Hui Wang; Ying Sheng; Qing Zhang; Jing Yan; Jin Hou; Kang Zhu; Ying Cheng; Ying-Long Xu; Xiang-Hong Zhang; Min Xu; Xiao-Yong Ren
Journal:  Med Oncol       Date:  2013-12-07       Impact factor: 3.064

5.  Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans.

Authors:  Archana Kamalakar; Manali S Bendre; Charity L Washam; Tristan W Fowler; Adam Carver; Joshua D Dilley; John W Bracey; Nisreen S Akel; Aaron G Margulies; Robert A Skinner; Frances L Swain; William R Hogue; Corey O Montgomery; Parshawn Lahiji; Jacqueline J Maher; Kim E Leitzel; Suhail M Ali; Alan Lipton; Richard W Nicholas; Dana Gaddy; Larry J Suva
Journal:  Bone       Date:  2014-01-28       Impact factor: 4.398

6.  Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors.

Authors:  Michael S Rogers; Katherine Novak; David Zurakowski; Lorna M Cryan; Anna Blois; Eugene Lifshits; Trond H Bø; Anne M Oyan; Elise R Bender; Michael Lampa; Soo-Young Kang; Kamila Naxerova; Karl-Henning Kalland; Oddbjorn Straume; Lars A Akslen; Randolph S Watnick; Judah Folkman; George N Naumov
Journal:  Mol Cancer Res       Date:  2014-02-26       Impact factor: 5.852

7.  The dominant role of IL-8 as an angiogenic driver in a three-dimensional physiological tumor construct for drug testing.

Authors:  Pamela H S Tan; Su Shin Chia; Siew Lok Toh; James C H Goh; Saminathan Suresh Nathan
Journal:  Tissue Eng Part A       Date:  2014-04-30       Impact factor: 3.845

8.  UDCA Inhibits Hypoxic Hepatocellular Carcinoma Cell-Induced Angiogenesis Through Suppressing HIF-1α/VEGF/IL-8 Intercellular Signaling.

Authors:  Wanfu Lin; Shu Li; Yongbin Meng; Guokai Huang; Shufang Liang; Juan Du; Qun Liu; Binbin Cheng
Journal:  Front Pharmacol       Date:  2021-12-15       Impact factor: 5.810

9.  CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis.

Authors:  Ai-Fang Huang; Min-Wei Chen; Shih-Ming Huang; Chu-Lien Kao; Hung-Cheng Lai; James Yi-Hsin Chan
Journal:  Mol Cancer       Date:  2013-10-05       Impact factor: 27.401

10.  Paracrine interleukin-8 affects mesenchymal stem cells through the Akt pathway and enhances human umbilical vein endothelial cell proliferation and migration.

Authors:  Lulu Wang; Yongtao Li; Xiaodong Zhang; Na Liu; Shiyang Shen; Shizhu Sun; Yang Jiang; Penghui Li; Haifeng Jin; Lei Shen
Journal:  Biosci Rep       Date:  2021-05-28       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.